Glucagon and glucagon-like peptides 1 and 2

Results and Problems in Cell Differentiation

Volumn 50, Issue , 2010, Pages 121-135

  Holst, Jens Juul ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCAGON LIKE PEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 2; PEPTIDE; PEPTIDE FRAGMENT; PROPROTEIN CONVERTASE 1; PROPROTEIN CONVERTASE 2;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; BRAIN STEM; CHEMISTRY; HUMAN; METABOLISM; NERVE CELL; PROTEIN PROCESSING;

ANIMALS; BRAIN STEM; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDE 2; GLUCAGON-LIKE PEPTIDES; HUMANS; MODELS, BIOLOGICAL; NEURONS; PEPTIDE FRAGMENTS; PEPTIDES; PROPROTEIN CONVERTASE 1; PROPROTEIN CONVERTASE 2; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 77950221874     PISSN: 00801844     EISSN: 18610412     Source Type: Book Series    
DOI: 10.1007/400_2009_35     Document Type: Article

References (109)

1. Baldissera FG, Holst JJ (1984) Glucagon-related peptides in the human gastrointestinal mucosa. Diabetologia 26:223-228
2. Baldissera FG, Holst JJ (1986) Glicentin 1-61 probably represents a major fraction of glucagonrelated peptides in plasma of anaesthetized uraemic pigs. Diabetologia 29:462-467
3. Bataille D (2007) Pro-protein convertases in intermediary metabolism: islet hormones, brain/gut hormones and integrated physiology. J Mol Med 85:673-684
4. Bataille D, Tatemoto K, Gespach C et al (1982) Isolation of glucagon-37 (bioactive enteroglucagon/ oxyntomodulin) from porcine jejuno-ileum. Characterization of the peptide. FEBS Lett 146:79-86
5. Bell GI, Sanchez-Pescador R, Laybourn PJ et al (1983a) Exon duplication and divergence in the human preproglucagon gene. Nature 304:368-371
6. Bell GI, Santerre RF, Mullenbach GT (1983b) Hamster preproglucagon contains the sequence of glucagon and two related peptides. Nature 302:716-718
7. Bottcher G, Alumets J, Hakanson R et al (1986) Co-existence of glicentin and peptide YY in colorectal L-cells in cat and man. An electron microscopic study. Regul Pept 13:283-291
8. Bryant MG, Bloom SR, Polak JM et al (1983) Measurement of gut hormonal peptides in biopsies from human stomach and proximal small intestine. Gut 24:114-119
9. Buffa R, Capella C, Fontana P et al (1978) Types of endocrine cells in the human colon and rectum. Cell Tissue Res 192:227-240
10. Buhl T, Thim L, Kofod H et al (1988) Naturally occurring products of proglucagon 111-160 in the porcine and human small intestine. J Biol Chem 263:8621-8624
11. Creutzfeldt WO, Kleine N, Willms B et al (1996) Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients. Diabetes Care 19:580-586
12. de Heer J, Rasmussen C, Coy DH et al (2008) Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas. Diabetologia 51:2263-2270
13. Deacon CF, Johnsen AH, Holst JJ (1995) Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo. J Clin Endocrinol Metab 80:952-957
14. Deacon CF, Pridal L, Klarskov L et al (1996) Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig. Am J Physiol 271:E458-E464
15. Deacon CF, Kelstrup M, Trebbien R et al (2003) Differential regional metabolism of glucagon in anesthetized pigs. Am J Physiol Endocrinol Metab 285:E552-E560
16. Drucker DJ (2006) The biology of incretin hormones. Cell Metab 3:153-165
17. Drucker DJ, Asa S (1988) Glucagon gene expression in vertebrate brain. J Biol Chem 263:13475-13478
18. Eissele R, Goke R, Willemer S et al (1992) Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man. Eur J Clin Invest 22:283-291
19. Flamez D, Van Breusegem A, Scrocchi LA et al (1998) Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene. Diabetes 47:646-652
20. Furuta M, Yano H, Zhou A et al (1997) Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2. Proc Natl Acad Sci USA 94:6646-6651
21. Gelling RW, Du XQ, Dichmann DS et al (2003) Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. Proc Natl Acad Sci USA 100:1438-1443
22. Grant SF, Thorleifsson G, Reynisdottir I et al (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38:320-323
23. Grimelius L, Capella C, Buffa R et al (1976) Cytochemical and ultrastructural differentiation of enteroglucagon and pancreatic-type glucagon cells of the gastrointestinal tract. Virchows Arch B Cell Pathol 20:217-228
24. Hansen L, Deacon CF, Orskov C et al (1999) Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine [In Process Citation]. Endocrinology 140:5356-5363
25. Hansen L, Hartmann B, Bisgaard T et al (2000) Somatostatin restrains the secretion of glucagonlike peptide-1 and 2 from isolated perfused porcine ileum. Am J Physiol 278:E1010-E1018
26. Hansen L, Hartmann B, Mineo H et al (2004) Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum. Regul Pept 118:11-18
27. Hartmann B, Harr MB, Jeppesen PB et al (2000a) In vivo and in vitro degradation of glucagonlike peptide-2 in humans. J Clin Endocrinol Metab 85:2884-2888
28. Hartmann B, Johnsen AH, Orskov C et al (2000b) Structure, measurement, and secretion of human glucagon-like peptide-2 [In Process Citation]. Peptides 21:73-80
29. Heinrich G, Gros P, Habener JF (1984) Glucagon gene sequence. Four of six exons encode separate functional domains of rat pre-proglucagon. J Biol Chem 259:14082-14087
30. Heller RS, Aponte GW (1995) Intra-islet regulation of hormone secretion by glucagon-like peptide-1- (7-36) amide. Am J Physiol 269:G852-G860
31. Hill ME, Asa SL, Drucker DJ (1999) Essential requirement for Pax6 in control of enteroendocrine proglucagon gene transcription. Mol Endocrinol 13:1474-1486
32. Holst JJ (1980) Evidence that glicentin contains the entire sequence of glucagon. Biochem J 187:337-343
33. Holst JJ (1982) Evidence that enteroglucagon (II) is identical with the C- terminal sequence (residues 33-69) of glicentin. Biochem J 207:381-388
34. Holst JJ (1991) Degradation of Glucagons. In: Henriksen JH (ed) Degradation of Bioactive Substances: Physiology and Pathophysiology. CRC, Boca Raton, pp 167-180
35. Holst JJ, Aggestrup S, Loud FB et al (1983a) Content and gel filtration profiles of glucagon-like and somatostatin- like immunoreactivity in human fundic mucosa. J Clin Endocrinol Metab 56:729-732
36. Holst JJ, Pedersen JH, Baldissera F et al (1983b) Circulating glucagon after total pancreatectomy in man. Diabetologia 25:396-399
37. Holst JJ, Orskov C, Nielsen OV et al (1987) Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut. FEBS Lett 211:169-174
38. Holst JJ, Bersani M, Johnsen AH et al (1994) Proglucagon processing in porcine and human pancreas. J BiolChem 269:18827-18833
39. Hupe-Sodmann K, Goke R, Goke B et al (1997) Endoproteolysis of glucagon-like peptide (GLP)-1 (7-36) amide by ectopeptidases in RINm5F cells. Peptides 18:625-632
40. Irwin DM, Wong J (1995) Trout and chicken proglucagon: alternative splicing generates mRNA transcripts encoding glucagon-like peptide 2. Mol Endocrinol 9:267-277
41. Jackson RS, Creemers JW, Farooqi IS et al (2003) Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. J Clin Invest 112:1550-1560
42. Jin SL, Han VK, Simmons JG et al (1988) Distribution of glucagonlike peptide I (GLP-I), glucagon, and glicentin in the rat brain: an immunocytochemical study. J Comp Neurol 271:519-532
43. Jin T (2008) Mechanisms underlying proglucagon gene expression. J Endocrinol 198:17-28
44. Kauth T, Metz J (1987) Immunohistochemical localization of glucagon-like peptide 1. Use of poly- and monoclonal antibodies. Histochemistry 86:509-515
45. Kieffer TJ, Habener JF (1999) The glucagon-like peptides. Endocr Rev 20:876-913
46. Knudsen JB, Holst JJ, Asnaes S et al (1975) Identification of cells with pancreatic-type and guttype glucagon immunoreactivity in the human colon. Acta Pathol Microbiol Scand [A] 83:741-743
47. Knudsen LB, Pridal L (1996) Glucagon-like peptide-1-(9-36) amide is a major metabolite of glucagon-like peptide-1-(7-36) amide after in vivo administration to dogs, and it acts as an antagonist on the pancreatic receptor. Eur J Pharmacol 318:429-435
48. Larsen PJ, Tang-Christensen M, Holst JJ et al (1997) Distribution of glucagon-like peptide-1 and other preproglucagon- derived peptides in the rat hypothalamus and brainstem. Neuroscience 77:257-270
49. Lee YC, Asa SL, Drucker DJ (1992) Glucagon gene 5'-flanking sequences direct expression of simian virus 40 large T antigen to the intestine, producing carcinoma of the large bowel in transgenic mice. J Biol Chem 267:10705-10708
50. Lefebvre PJ, Luyckx AS (1980) Neurotransmitters and glucagon release from the isolated, perfused canine stomach. Diabetes 29:697-701
51. List JF, He H, Habener JF (2006) Glucagon-like peptide-1 receptor and proglucagon expression in mouse skin. Regul Pept 134:149-157
52. Lopez LC, Frazier ML, Su CJ et al (1983) Mammalian pancreatic preproglucagon contains three glucagon- related peptides. Proc Natl Acad Sci USA 80:5485-5489
53. Lotfi S, Li Z, Sun J et al (2006) Role of the exchange protein directly activated by cyclic adenosine 5'-monophosphate (Epac) pathway in regulating proglucagon gene expression in intestinal endocrine L cells. Endocrinology 147:3727-3736
54. Lund PK, Goodman RH, Dee PC et al (1982) Pancreatic preproglucagon cDNA contains two glucagonrelated coding sequences arranged in tandem. Proc Natl Acad Sci USA 79:345-349
55. Ma X, Zhang Y, Gromada J et al (2005) Glucagon stimulates exocytosis in mouse and rat pancreatic alpha-cells by binding to glucagon receptors. Mol Endocrinol 19:198-212
56. Masur K, Tibaduiza EC, Chen C et al (2005) Basal receptor activation by locally produced glucagonlike peptide-1 contributes to maintaining beta-cell function. Mol Endocrinol 19:1373-1382
57. McKinnon CM, Ravier MA, Rutter GA (2006) FoxO1 is required for the regulation of preproglucagon gene expression by insulin in pancreatic alphaTC1-9 cells. J Biol Chem 281:39358-39369
58. Meier JJ, Nauck MA, Kranz D et al (2004) Secretion, degradation, and elimination of glucagonlike peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects. Diabetes 53:654-662
59. Mojsov S, Heinrich G, Wilson IB et al (1986) Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. J Biol Chem 261:11880-11889
60. Mojsov S, Weir GC, Habener JF (1987) Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest 79:616-619
61. Mojsov S, Kopczynski MG, Habener JF (1990) Both amidated and nonamidated forms of glucagon-like peptide I are synthesized in the rat intestine and the pancreas. J Biol Chem 265:8001-8008
62. Moody AJ, Holst JJ, Thim L et al (1981) Relationship of glicentin to proglucagon and glucagon in the porcine pancreas. Nature 289:514-516
63. Mortensen K, Christensen LL, Holst JJ et al (2003) GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine. Regul Pept 114:189-196
64. Murlin JR, Clough HD, Gibbs CBF et al (1923) Aqueous extracts of the pancreas. I. Influence on the carbohydrate metabolism of depancreatized animals. J Biol Chem 56:253-296
65. Nian M, Drucker DJ, Irwin D (1999) Divergent regulation of human and rat proglucagon gene promoters in vivo. Am J Physiol 277:G829-G837
66. Nian M, Gu J, Irwin DM et al (2002) Human glucagon gene promoter sequences regulating tissuespecific versus nutrient-regulated gene expression. Am J Physiol Regul IntegrComp Physiol 282:R173-R183
67. Nie Y, Nakashima M, Brubaker PL et al (2000) Regulation of pancreatic PC1 and PC2 associated with increased glucagon-like peptide 1 in diabetic rats. J Clin Invest 105:955-965
68. Novak U, Wilks A, Buell G et al (1987) Identical mRNA for preproglucagon in pancreas and gut. Eur J Biochem 164:553-558
69. Orci L, Bordi C, Unger RH et al (1983) Glucagon- and glicentin-producing cells. In: Lefebvre PJ (ed) Glucagon. Springer, Berlin
70. Orci L, Pictet R, Forssmann WG et al (1968) Structural evidence for glucagon producing cells in the intestinal mucosa of the rat. Diabetologia 4:56-67
71. Orskov C, Bersani M, Johnsen AH et al (1989) Complete sequences of glucagon-like peptide-1 from human and pig small intestine. J Biol Chem 264:12826-12829
72. Orskov C, Holst JJ, Knuhtsen S et al (1986) Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas. Endocrinology 119:1467-1475
73. Orskov C, Holst JJ, Poulsen SS et al (1987) Pancreatic and intestinal processing of proglucagon in man. Diabetologia 30:874-881
74. Orskov C, Rabenhoj L, Wettergren A et al (1994) Tissue and plasma concentrations of amidated and glycine- extended glucagon-like peptide I in humans. Diabetes 43:535-539
75. Orskov C, Wettergren A, Holst JJ (1993) Biological effects and metabolic rates of glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 in healthy subjects are indistinguishable. Diabetes 42:658-661
76. Patzelt C, Schug G (1981) The major proglucagon fragment: an abundant islet protein and secretory product. FEBS Lett 129:127-130
77. Pedersen NB, Hjollund KR, Johnsen AH et al (2008) Porcine glucagon-like peptide-2: structure, signaling, metabolism and effects. Regul Pept 146:310-320
78. Philippe J (1991) Insulin regulation of the glucagon gene is mediated by an insulin-responsive DNA element. Proc Natl Acad Sci USA 88:7224-7227
79. Pilgaard K, Jensen CB, Schou JH et al (2009) The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men. Diabetologia 52:1298-1307
80. Plamboeck A, Holst JJ, Carr RD et al (2005) Neutral endopeptidase 24.11 and dipeptidyl peptidase IV are both mediators of the degradation of glucagon-like peptide 1 in the anaesthetised pig. Diabetologia 48:1882-1890
81. Rouille Y, Kantengwa S, Irminger JC et al (1997) Role of the prohormone convertase PC3 in the processing of proglucagon to glucagon-like peptide 1. J Biol Chem 272:32810-32816
82. Rouille Y, Westermark G, Martin SK et al (1994) Proglucagon is processed to glucagon by prohormone convertase PC2 in alpha TC1-6 cells. Proc Natl Acad Sci USA 91:3242-3246
83. Schafer SA, Tschritter O, Machicao F et al (2007) Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms. Diabetologia 50:2443-2450
84. Schinner S, Barthel A, Dellas C et al (2005) Protein kinase B activity is sufficient to mimic the effect of insulin on glucagon gene transcription. J Biol Chem 280:7369-7376
85. Scrocchi LA, Hill ME, Saleh J et al (2000) Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action. Diabetes 49:1552-1560
86. Shu L, Matveyenko AV, Kerr-Conte J et al (2009) Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function. Hum Mol Genet 18:2388-2399
87. Sundby F, Jacobsen H, Moody AJ (1976) Purification and characterization of a protein from porcine gut with glucagon-like immunoreactivity. Horm Metab Res 8:366-371
88. Sundler F, Alumets J, Holst J et al (1976) Ultrastructural identification of cells storing pancreatictype glucagon in dog stomach. Histochemistry 50:33-37
89. Sutherland EW, De Duve C (1948) Origin and distribution of the hyperglycemic-glycogenolytic factor of the pancreas. J Biol Chem 175:663-674
90. Thim L, Moody AJ (1981) The amino acid sequence of porcine glicentin. Peptides 2(Suppl 2):37-39
91. Thim L, Moody AJ (1982) Purification and chemical characterization of a glicentin- related pancreatic peptide (proglucagon fragment) from porcine pancreas. Biochim Biophys Acta 703:134-141
92. Trebbien R, Klarskov L, Olesen M et al (2004) Neutral endopeptidase 24.11 is important for the degradation of both endogenous and exogenous glucagon in anesthetized pigs. Am J Physiol Endocrinol Metab 287:E431-E438
93. Trinh DK, Zhang K, Hossain M et al (2003) Pax-6 activates endogenous proglucagon gene expression in the rodent gastrointestinal epithelium. Diabetes 52:425-433
94. Ugleholdt R, Zhu X, Deacon CF et al (2004) Impaired intestinal proglucagon processing in mice lacking prohormone convertase 1. Endocrinology 145:1349-1355
95. Unger RH, Eisentraut AM, McCall RH et al (1961) Glucagon antibodies and an immunoassay for glucagon. J Clin Invest 40:1280-1289
96. Unger RH, Ketterer H, Eisentraut AM (1966) Distribution of immunoassayable glucagon in gastrointestinal tissues. Metabolism 15:865-867
97. Unger RH, Ohneda A, Valverde I et al (1968) Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose. J Clin Invest 47:48-65
98. Valverde I, Rigopoulou D, Exton J et al (1968) Demonstration and characterization of a second fraction of glucagon- like immunoreactivity in jejunal extracts. Am J Med Sci 255:415-420
99. Varndell IM, Bishop AE, Sikri KL et al (1985) Localization of glucagon-like peptide (GLP) immunoreactants in human gut and pancreas using light and electron microscopic immunocytochemistry. J Histochem Cytochem 33:1080-1086
100. Vilsboll T, Agerso H, Krarup T et al (2003) Similar elimination rates of glucagon-like peptide-1 in obese type 2 diabetic patients and healthy subjects. J Clin Endocrinol Metab 88:220-224
101. Vilsboll T, Krarup T, Deacon CF et al (2000) Reduced concentrations of intact and total GIP and GLP-1 in type 2 diabetic patients
102. Vilsbøll T, Krarup T, Deacon CD, Madsbad S, Holst JJ (2001) Reduced concentrations of intact and total GIP and GLP-1 in type 2 diabetic patients. Diabetes 50:609-613
103. Wettergren A, Pridal L, Wojdemann M, Holst JJ (1998) Amidated and non-amidated glucagonlike peptide-1 (GLP-1): non-pancreatic effects (cephalic phase acid secretion) and stability in plasma in humans. Regul Pept 77:83-87
104. Wideman RD, Yu IL, Webber TD et al (2006) Improving function and survival of pancreatic islets by endogenous production of glucagon-like peptide 1 (GLP-1). Proc Natl Acad Sci USA 103: 13468-13473
105. Wilson ME, Kalamaras JA, German MS (2002) Expression pattern of IAPP and prohormone convertase 1/3 reveals a distinctive set of endocrine cells in the embryonic pancreas. Mech Dev 115:171-176
106. Yi F, Brubaker PL, Jin T (2005) TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. J Biol Chem 280:1457-1464
107. Zander M, Madsbad S, Deacon CF et al (2006) The metabolite generated by dipeptidyl-peptidase 4 metabolism of glucagon-like peptide-1 has no influence on plasma glucose levels in patients with type 2 diabetes. Diabetologia 49:369-374
108. Zhou L, Nian M, Gu J et al (2006) Intron 1 sequences are required for pancreatic expression of the human proglucagon gene. Am J Physiol Regul Integr Comp Physiol 290:R634-R641
109. Zhu X, Zhou A, Dey A et al (2002) Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects. Proc Natl Acad Sci USA 99:10293-10298